NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ · Healthcare
NeuroOne Medical Technologies Corporation EBITDA 2020–2025
NeuroOne Medical Technologies Corporation annual/quarterly ebitda history and growth rate from 2020 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- NeuroOne Medical Technologies Corporation ebitda for the quarter ending March 31, 2026 was -2.0 M, a 22.27% decrease year-over-year.
- NeuroOne Medical Technologies Corporation ebitda for the twelve months ending March 31, 2026 was -6.6 M.
- NeuroOne Medical Technologies Corporation annual ebitda for 2025 was -3.8 M, a 67.05% decrease from 2024.
- NeuroOne Medical Technologies Corporation annual ebitda for 2024 was -11.5 M, a 1.24% decrease from 2023.
- NeuroOne Medical Technologies Corporation annual ebitda for 2023 was -11.7 M, a 17.64% increase from 2022.
- NeuroOne Medical Technologies Corporation annual ebitda for 2022 was -9.9 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
NeuroOne Medical Technologies Corporation EBITDA — FAQ
NeuroOne Medical Technologies Corporation (NMTC) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NMTC's ebitda history?
The chart and table above show NeuroOne Medical Technologies Corporation's ebitda by year and by quarter, including the growth rate.